Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study.

Edwards CJ, Campbell J, van Staa T, Arden NK.

BMJ Open. 2012 Nov 8;2(6). pii: e001603. doi: 10.1136/bmjopen-2012-001603. Print 2012.

2.
3.

Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.

Kim SC, Yelin E, Tonner C, Solomon DH.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1529-33. doi: 10.1002/acr.21997.

4.

Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.

Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski ML, Farley JF.

J Manag Care Spec Pharm. 2014 Nov;20(11):1110-20.

5.

Disease-modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice.

Montag K, Gingold M, Boers A, Littlejohn G.

Intern Med J. 2011 Jun;41(6):450-5. doi: 10.1111/j.1445-5994.2010.02240.x. Epub 2010 Apr 12.

PMID:
20403067
6.
7.

Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.

Gibofsky A, Palmer WR, Goldman JA, Lautzenheiser RL, Markenson JA, Weaver A, Schiff MH, Keystone EC, Paulus HE, Harrison MJ, Whitmore JB, Leff JA.

Curr Med Res Opin. 2006 Jan;22(1):169-83.

PMID:
16393443
8.

Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.

Bonafede MM, Fox KM, Johnson BH, Watson C, Gandra SR.

Clin Ther. 2012 Feb;34(2):457-67. doi: 10.1016/j.clinthera.2011.12.016. Epub 2012 Jan 28.

PMID:
22284901
9.

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.

Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH.

Arthritis Rheum. 2007 Aug 15;57(6):928-34.

10.

Patterns of drug use in rheumatoid arthritis.

Bérard A, Solomon DH, Avorn J.

J Rheumatol. 2000 Jul;27(7):1648-55.

PMID:
10914846
11.

Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Osiri M, Deesomchok U, Tugwell P.

Clin Rheumatol. 2006 Sep;25(5):721-7. Epub 2005 Dec 20.

PMID:
16365685
12.

Etanercept for the treatment of rheumatoid arthritis.

Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. Review.

PMID:
23728649
13.

Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey.

Solomon DH, Ayanian JZ, Yelin E, Shaykevich T, Brookhart MA, Katz JN.

Arthritis Care Res (Hoboken). 2012 Feb;64(2):184-9. doi: 10.1002/acr.20674.

14.

Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients.

Jin XM, Lee J, Choi NK, Seong JM, Shin JY, Kim YJ, Kim MS, Yang BR, Park BJ.

J Korean Med Sci. 2014 Feb;29(2):210-6. doi: 10.3346/jkms.2014.29.2.210. Epub 2014 Jan 28.

15.

[Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].

Ndongo S, Pouye A, Lekpa FK, Bihéhé DM, Tiendrebeogo J, Ndao AC, Ka MM, Moreira Diop T.

Med Sante Trop. 2012 Oct-Dec;22(4):385-9. doi: 10.1684/mst.2012.0096. French.

17.

[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].

Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.

Z Rheumatol. 2004 Feb;63(1):59-75. German.

PMID:
14991279
18.
19.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
20.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080

Supplemental Content

Support Center